small molecule medical device potentiators for cardiovascular disease (Resverlogix/Medtronic)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesmall molecule medical device potentiators for cardiovascular disease (Resverlogix/Medtronic)
Drug Alias NameReVas
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesResverlogix Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A